Options for Endocrine-Refractory, Hormone Receptor-Positive Breast Cancer: Which Target and When? Borges VF. J Clin Oncol 2021 Oct 28:JCO2101910. doi: 10.1200/JCO.21.01910.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Borges VF. Options for Endocrine-Refractory, Hormone Receptor-Positive Breast Cancer: Which Target and When? J Clin Oncol 2021 Oct 28:JCO2101910. doi: 10.1200/JCO.21.01910.
PMID: 34709849